StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$690.24−10.41 (-1.49%)

Close on Nov 17, 2026Market cap $54.38BP/E 48.5Yield –

IDEXX Laboratories enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

IDEXX Laboratories's enterprise value was $55.67B on Nov 11, 2026, against $60.55B a year earlier. Over the last 5 years it ranged from $27.83B to $60.55B, with a median of $41.96B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$55.67B+2.3%
2025Dec 31, 2025$54.44B+59.0%
2024Dec 31, 2024$34.23B-26.5%
2023Dec 29, 2023$46.54B+34.8%
2022Dec 30, 2022$34.52B-39.0%
2021Dec 31, 2021$56.60B+30.5%
2020Dec 31, 2020$43.37B+94.3%
2019Dec 31, 2019$22.32B+39.9%
2018Dec 31, 2018$15.95B+17.2%
2017Dec 29, 2017$13.61B+32.2%
2016Dec 30, 2016$10.30B+63.4%
2015Dec 31, 2015$6.30B-14.8%
2014Dec 31, 2014$7.39B+33.0%
2013Dec 31, 2013$5.56B+10.8%
2012Dec 31, 2012$5.01B+15.6%
2011Dec 30, 2011$4.34B+8.2%
2010Dec 31, 2010$4.01B+23.5%
2009Dec 31, 2009$3.25B–

More IDEXX Laboratories figures

See a number that looks wrong?